FDA NDC Directory · JSON-LD · Markdown

Carglumic acid

NDC 35573-459 · HUMAN PRESCRIPTION DRUG · TABLET, FOR SUSPENSION

Labeler / ManufacturerBurel Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA213395
Dosage form / routeTABLET, FOR SUSPENSION · ORAL
Active ingredientsCARGLUMIC ACID (200 mg/1)
Marketing started20221219
Package count1

External sources

Source: openFDA. Public-domain (CC0).